Nordicus Partners (NORD) EBITDA Margin (2009 - 2019)
Nordicus Partners (NORD) posted EBITDA Margin of 22.02% for fiscal Q2 2020 (quarter ended Sep 30, 2019), up 6.78 percentage points from 15.24% a year earlier but down 1734.58 percentage points from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) EBITDA Margin (2009 - 2019) Analysis & Trends
For FY2019 (ended Mar 31, 2019), Nordicus Partners' EBITDA Margin came in at 24.33%, down 222.01 percentage points from FY2018.
- Annual EBITDA Margin shows a five-year change of +21.41 percentage points (FY2014 to FY2019).
- In prior fiscal years, Nordicus Partners' EBITDA Margin was 246.33% in FY2018 (+252.20 pp), -5.87% in FY2017 (-18.79 pp), 12.92% in FY2016 (+0.03 pp) and 12.89% in FY2015 (+9.98 pp).
- Quarterly EBITDA Margin has run from a low of -71.81% in fiscal Q4 2016 to a high of 1756.60% in fiscal Q1 2020 over five years.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was fiscal Q1 2020, with a gain of 1076.97 percentage points; the weakest was fiscal Q4 2016, with a drop of 112.30 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Nordicus Partners | 55.60 Mn | 55.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 22.02% |
| Jun 30, 2019 | 1,756.60% |
| Dec 31, 2018 | 77.39% |
| Sep 30, 2018 | 15.24% |
| Jun 30, 2018 | 679.63% |
| Dec 31, 2017 | 8.85% |
| Sep 30, 2017 | -33.76% |
| Jun 30, 2017 | 3.40% |
| Mar 31, 2017 | -34.96% |
| Dec 31, 2016 | -16.49% |
| Sep 30, 2016 | -1.71% |
| Jun 30, 2016 | 16.38% |
| Mar 31, 2016 | -71.28% |
| Dec 31, 2015 | -3.38% |
| Sep 30, 2015 | 26.32% |
| Jun 30, 2015 | 36.89% |
| Mar 31, 2015 | 40.56% |
| Dec 31, 2014 | -18.11% |
| Sep 30, 2014 | -13.54% |
| Jun 30, 2014 | -5.15% |
API Access
Nordicus Partners EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();